CUBAN DRUG OUTPUT, PRESCRIBING MOVES

12 June 1994

Cuba's Public Health Minister, Julio Teja, has told the Havana-based Granma International journal that the output of the national pharmaceutical industry should be 84 million pesos ($63.6 million) in 1994, given adequate supplies of raw materials. This would be similar to 1992's level but much higher than 1993's production total of 59.7 million pesos.

Current supplies of pharmaceutical raw materials are healthy, thanks to forward planning, the Minister said, adding that the Ministry is working "doggedly" to overcome shortages of some medicines and other supplies. He said there is no evidence of a decline in the principal health indices as a result of these shortages.

Mr Teja also announced that an integral strategy for national drug production has been formulated, along with a more rigorous control system for dispensing drugs via prescriptions, and greater government support for continued development of "natural" and traditional medicines. The dispensing reform mainly involves changes to the prescription form, in order to make it harder for people to obtain medicines to sell for personal gain and reduce the number of drugs in short supply. In a change which began in Havana on May 16 and will gradually be extended throughout the country, those obtaining drugs from pharmacies will now have to present two forms.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight